Background Changes in body fat distribution are a frequent finding in individuals with HIV
infection. Lipoatrophy, or decreased subcutaneous fat in the limbs together with prominent …

Recent reports of localized areas of increased fat deposition and fat loss in HIV-infected
patients, as well as changes in serum levels of metabolites and hormones, have led to the …

Body fat disorders are a common and relevant problem in HIV-1-infected patients that can
be associated with metabolic alterations. Many controversies in their definition …

Objective To determine if fat distribution is altered in HIV‐infected men without clinical
evidence of lipodystrophy. Methods In a cross‐sectional design, 14 protease inhibitor (PI) …

To identify clinical factors associated with the incidence of HIV-1-associated lipoatrophy, HIV-
1-infected patients in the HIV Outpatient Study (HOPS) were prospectively evaluated for …

Peripheral and central lipoatrophy affecting subcutaneous fat is emerging as the dominant
morphologic change associated with HIV infection when compared with those without …

Objective To identify clinical factors associated with prevalence of fat atrophy (lipoatrophy)
and fat accumulation (lipoaccumulation) in HIV-1 infected patients. Design Evaluation of HIV …

In developed countries, the availability of highly active antiretroviral therapy (HAART) has
contributed to a dramatic decrease in mortality and opportunistic infections associated with …

In the late 1990s, reports of unusual changes in body fat distribution named
'lipodystrophy'(LD) began to appear in HIV patients mitigating the enormous enthusiasm …

Lipodystrophy is a common alteration in HIV 1-infected patients under anti-retroviral
treatment. This syndrome is usually associated with peripheral lipoatrophy, central adiposity …